Resmed – First Linde Then CNBC And Jim Cramer

You will recall two days ago the market noise that Resmed was about to be picked up by German Linde. We blogged about it here.

Now CNBC’s Jim Cramer talked about them benefiting from the potential reversal or low impact of competitive bidding. (I don’t think competitive bidding will be substantially reversed just to be clear.

Jim Cramer goes on to issue a potential target price of $53 which is a cool 30% premium.

Related posts:

1. Would a Linde Acquisition Of Resmed Make Sense?
2. (Happy?) Birthday National Competitive Bidding – Medicare – Homecare
3. The New York Times Slams Congress On Medicare And National Competitive Bidding Delays -Names Industry Players
4. George Bush Veto Of National Competitive Bidding Overturned By Congress and The Senate
5. It’s Not Just About Invacare And The Scooterstore And Competitive Bidding